Page last updated: 2024-10-27

gliclazide and Bonnevie-Ullrich Syndrome

gliclazide has been researched along with Bonnevie-Ullrich Syndrome in 1 studies

Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.

Bonnevie-Ullrich Syndrome: This syndrome that was originally observed by Ullrich, and designated as identical to TURNER SYNDROME, related the webbing of the neck, loose skin and other anomalies of the syndrome to accumulation of fluid in the embryo starting at the head and dispersing to the extremities (as observed by Bonnevie in mice). Commonly observed at birth in Turner Syndrome and NOONAN SYNDROME; EDEMA of the extremities usually recedes by one year and is an early sign of Turner syndrome, especially in female neonates.

Research Excerpts

ExcerptRelevanceReference
"We evaluated insulin resistance and assessed the effect of gliclazide on insulin resistance in a patient with diabetes mellitus associated with Turner's syndrome."3.69Insulin resistance in a patient with diabetes mellitus associated with Turner's syndrome. ( Hashimoto, K; Hisatake, K; Kumon, Y; Suehiro, T; Sumiyoshi, R, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumon, Y1
Hisatake, K1
Suehiro, T1
Sumiyoshi, R1
Hashimoto, K1

Other Studies

1 other study available for gliclazide and Bonnevie-Ullrich Syndrome

ArticleYear
Insulin resistance in a patient with diabetes mellitus associated with Turner's syndrome.
    Internal medicine (Tokyo, Japan), 1994, Volume: 33, Issue:9

    Topics: Adult; Diabetes Complications; Diabetes Mellitus; Female; Gliclazide; Glucose Clamp Technique; Gluco

1994